SEC Form 4 · accession 0001209191-16-109074
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark McDade
Director
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 2:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $32.11 | Mar 15, 2016 | A | 10,000 | A | — | Mar 15, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1One-third (1/3) of the shares underlying the option will vest on each anniversary of March 15, 2016.